78 related articles for article (PubMed ID: 3264351)
1. [Application of the immunohistochemical method as predictive assay in radiotherapy of squamous cell carcinoma].
Ogawa Y; Inomata T; Maeda T; Seguchi H; Nishioka A; Terashima M; Kishimoto S; Saito H; Hirota S; Osaki T
Gan No Rinsho; 1988 Oct; 34(13):1799-810. PubMed ID: 3264351
[TBL] [Abstract][Full Text] [Related]
2. Application of the immunohistochemical method as a predictive assay in radiotherapy of squamous cell carcinoma of oropharynx and hypopharynx.
Ogawa Y; Maeda T; Seguchi H; Inomata T; Yoshida S; Kishimoto S; Saito H
Oncology; 1990; 47(2):155-9. PubMed ID: 2314828
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of c-fos-positive lymphocytes infiltrated into human squamous cell carcinomas of the head and neck during radiation therapy and its clinical significance.
Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2301-7. PubMed ID: 9815628
[TBL] [Abstract][Full Text] [Related]
4. [Radiotherapy and tumor immunity--analysis using monoclonal antibodies].
Ogawa Y; Maeda T; Seguchi H; Hamada F; Inomata T; Yoshida S; Kishimoto S; Saito H; Osaki T
Gan No Rinsho; 1987 Aug; 33(10):1221-8. PubMed ID: 2444726
[TBL] [Abstract][Full Text] [Related]
5. Expression of fas (CD95/APO-1) antigen induced by radiation therapy for diffuse B-cell lymphoma: immunohistochemical study.
Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2211-6. PubMed ID: 9815617
[TBL] [Abstract][Full Text] [Related]
6. Fibronectin expression in cancer tissues from patients undergoing radiation therapy.
Nishioka A; Ogawa Y; Inomata T; Maeda T; Seguchi H
Histol Histopathol; 1993 Jul; 8(3):457-62. PubMed ID: 8358157
[TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemical study of fibronectin expression in cancer tissue before and after irradiation].
Nishioka A; Ogawa Y; Inomata T; Maeda T
Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Sep; 51(9):1087-97. PubMed ID: 1945790
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics, biodistribution, and dosimetry of specific and control radiolabeled monoclonal antibodies in patients with primary head and neck squamous cell carcinoma.
Maraveyas A; Stafford N; Rowlinson-Busza G; Stewart JS; Epenetos AA
Cancer Res; 1995 Mar; 55(5):1060-9. PubMed ID: 7866989
[TBL] [Abstract][Full Text] [Related]
11. [Influence of radiotherapy on lymphocyte subpopulations].
Ceschia T; Beorchia A; Guglielmi R; Mandoliti G; Fongione S; Cereghini M; Tonutti E; Sala PG; Pizzi G
Radiol Med; 1991 Apr; 81(4):532-6. PubMed ID: 2028047
[TBL] [Abstract][Full Text] [Related]
12. [An immunohistochemical study with monoclonal antibodies on lymphocytes infiltrating in cervical cancer].
Okamoto Y; Sano T; Okamura S; Ueki M; Sugimoto O
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jun; 39(6):925-32. PubMed ID: 3302069
[TBL] [Abstract][Full Text] [Related]
13. Identification of subsets of lymphocytes infiltrating head and neck tumor tissue: a preliminary report.
Rabin BS; Johnson J; Claassen D
Laryngoscope; 1984 May; 94(5 Pt 1):688-90. PubMed ID: 6232437
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical research for T cell subsets infiltrating in squamous cell carcinoma of oral cavity by monoclonal antibody].
Lu DH
Zhonghua Kou Qiang Yi Xue Za Zhi; 1992 Jan; 27(1):34-6, 62. PubMed ID: 1499396
[TBL] [Abstract][Full Text] [Related]
15. [Local immunotherapy with OK-432 for malignant gliomas--immunohistochemical analysis of chronological changes of tumor tissues].
Saito T; Tanaka R; Sekiguchi K; Yoshida S; Washiyama K; Yamada N; Takeda N
No To Shinkei; 1988 Jul; 40(7):609-15. PubMed ID: 3224036
[TBL] [Abstract][Full Text] [Related]
16. Carboplatin and radiotherapy in the treatment of head and neck cancer: six years' experience.
Zamboglou N; Schnabel T; Kolotas C; Achterrath W; Strehl H; Dalhäuser S; Vogt HG; Lenaz L; Schmitt G
Semin Oncol; 1994 Oct; 21(5 Suppl 12):45-53. PubMed ID: 7992066
[TBL] [Abstract][Full Text] [Related]
17. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
18. Outcomes after radiotherapy for basaloid squamous cell carcinoma of the head and neck: a case-control study.
Thariat J; Ahamad A; El-Naggar AK; Williams MD; Holsinger FC; Glisson BS; Allen PK; Morrison WH; Weber RS; Ang KK; Garden AS
Cancer; 2008 Jun; 112(12):2698-709. PubMed ID: 18429002
[TBL] [Abstract][Full Text] [Related]
19. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck.
Kuss I; Hathaway B; Ferris RL; Gooding W; Whiteside TL
Clin Cancer Res; 2004 Jun; 10(11):3755-62. PubMed ID: 15173082
[TBL] [Abstract][Full Text] [Related]
20. An immunological outcome predictive score for head and neck carcinoma patients.
Kaffenberger W; Hölzer-Müller L; Auberger T; Clasen BP; Hohlmeier G; van Beuningen D
Strahlenther Onkol; 1995 Aug; 171(8):444-53. PubMed ID: 7652667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
